Showing 1 - 10 of 71
Persistent link: https://www.econbiz.de/10005259418
Persistent link: https://www.econbiz.de/10005143681
Persistent link: https://www.econbiz.de/10005224506
Persistent link: https://www.econbiz.de/10005224885
Persistent link: https://www.econbiz.de/10012093585
Persistent link: https://www.econbiz.de/10005409256
Our paper is a first attempt to evaluate the long run impact of reference pricing on pharmaceutical innovation, health and expenditures. The model is based on a dynamic game involving three types of agents: pharmaceutical firms, consumers and a regulatory entity. Pharmaceutical firms choose the...
Persistent link: https://www.econbiz.de/10008499168
Persistent link: https://www.econbiz.de/10009745617
Persistent link: https://www.econbiz.de/10009655149
Persistent link: https://www.econbiz.de/10010363381